Analysts' Actions: AAPL, BAC, F, APOL

NEW YORK ( TheStreet) -- CHANGE IN RATINGS

American Equity Investment ( AEL) upgraded to buy at TheStreet Ratings.

Apollo ( APOL) downgraded at Credit Suisse from Outperform to Neutral, Credit Suisse said. $40 price target. Company may struggle to maintain recent growth momentum.

Bank of America ( BAC) downgraded at Baird from Outperform to Neutral, Robert Baird said. $10 price target. Valuation call, as the stock has gained 80% year-to-date.

Buffalo Wild Wings ( BWLD) downgraded at Deutsche from Buy to Hold, Deutsche Bank said. Valuation call, based on a $100 price target.

Brookfield Office Properties ( BPO) upgraded to buy at TheStreet Ratings.

Electronic Arts ( EA) rated new Buy at Stifel. $21 price target. Star Wars can drive growth over the coming quart.

First Republic Bank ( FRC) rated new Outperform at BMO Capital Markets. $39 price target. Differentiated by high levels of client service.

KBR ( KBR) downgraded at Lazard from Buy to Neutral, Lazard said. Company lacks material growth drivers.

Southern Copper ( SCCO) upgraded at Morgan Stanley from Equal-weight to Overweight, Morgan Stanley said. Valuation call, based on a $43 price target.

Vale ( VALE) upgraded at Morgan Stanley from Equal-weight to Overweight, Morgan Stanley said. $29.60 price target. Company is leveraged to higher demand from China.

Williams Companies ( WMB) upgraded at UBS to Buy from Neutral, UBS said. $36 price target. Higher growth outlook and improved guidance.

STOCK COMMENTS / EPS CHANGES

Apple ( AAPL) target raised at Think to $700, ThinkEquity said. Positive launch of the new iPad and strong upcoming products. Buy rating.

Allergan ( AGN) target increased at Citigroup to $110, Citigroup said. Pipeline supports sustainable long term growth. Buy rating.

Apollo ( APOL) estimates cut at Jefferies through 2013, Jefferies said. New starts outlook in uninspiring. Perform rating.

BorgWarner ( BWA) estimates, target raised at Morgan Stanley. Shares of BWA now seen reaching $100, according to Morgan Stanley. Estimates also increased, as the company can continue to expand margins. Overweight rating.

Cintas ( CTAS) estimates, target boosted at Morgan Stanley. Shares of CTAS now seen reaching $32, according to Morgan Stanley. Estimates also upped, as the company is seeing higher sales and keeping a lid on costs. Underweight rating.

Dollar General ( DG) estimates upped at Guggenheim through 2013, Guggenheim said. Company is buying back more stock. Buy rating and $54 price target.

Ford Motor ( F) estimates increased at Morgan Stanley through 2013, Morgan Stanley said. Domestic sales continue to increase. Overweight rating and $18 price target.

Finish Line ( FINL) numbers upped at Jefferies. FINL estimates were boosted through 2013, Jefferies said. Solid sales growth should drive higher margins. Buy rating and new $29 price target.

JP Morgan ( JPM) numbers raised at BofA/Merrill. Shares of JPM now seen reaching $52, according to Bank of America/Merrill Lynch said. Estimates also increased, given better core trading and mortgage banking revenue.

McKesson ( MCK) estimates raised at Goldman through 2014, Goldman Sachs said. Significant contribution from Katz Group acquisition. Buy rating.

McGraw-Hill ( MHP) numbers raised at Benchmark. Shares of MHP now seen reaching $52, according to Benchmark. Estimates also increased, given a better environment for bond issuances. Hold rating.

Red Hat ( RHT) target raised at UBS to $54, UBS said. See upside to Q4 billings. Neutral rating.

Rent-A-Center ( RCII) upgraded at Stifel from Hold to Buy, Stifel Nicolaus said. $48 price target. Acceptance kiosks can help drive near-term growth.

St. Jude ( STJ) target boosted at Credit Suisse to $49, according to Credit Suisse. Domestic volumes should improve in 2012. Outperform rating.

Tibco ( TIBX) target raised at ThinkEquity to $36, according to ThinkEquity. Company can continue to generate solid salse growth. Buy rating.

Verisk ( VRSK) estimates, target increased at Credit Suisse. VRSK estimates were raised through 2013, Credit Suisse said. MediConnect deal should add to earnings. Outperform rating and new $53 price target.

>To submit a news tip, email: tips@thestreet.com.

RELATED STORIES:


Follow TheStreet on Twitter and become a fan on Facebook.
This article was written by a staff member of TheStreet.